Therapy News and Research

RSS

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

CHF International, the Silver Spring-MD based international development and humanitarian assistance organization, announced it signed an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to implement a two-year HIV and AIDS program in Colombia, with the possibility to extend it for another three years.

11 Mar 2011

Texas Children's completes first phase of certification to implant SynCardia temporary Total Artificial Heart

Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.

11 Mar 2011

Researchers uncover new disease mechanism in patients with CGD

Infection researchers at Umeå University have uncovered a new disease mechanism in patients with Chronic Granulomatous Disease in an international clinical collaboration with the Children's Hospital in Zurich.

11 Mar 2011

IHS opens new GE Discovery ST PET/CT system at Laurel imaging facility

Imaging Healthcare Specialists (IHS) is proud to announce the opening of a new GE Discovery ST PET/CT system at its Laurel imaging facility in Hillcrest. With the opening of this new scanner, IHS now offers state-of-art PET/CT imaging at two locations, in Hillcrest and in Encinitas.

11 Mar 2011

CWRU: Postmenopausal women need more dental checkups

Postmenopausal women have a new health message to hear. Two annual dental checkups aren't enough. Older women need more, according to research findings from the Case Western Reserve University School of Dental Medicine and the Cleveland Clinic.

11 Mar 2011

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

Caliper Life Sciences, Inc. and HistoRx, Inc., today announced a collaboration to co-develop a new generation of tissue-based imaging and analysis solutions, based on immuno-fluorescence, that will deliver accurate, quantitative, and reproducible measurements of proteins in tissue samples.

11 Mar 2011

SAP may serve as effective nanomaterial to prevent prostate cancer spread

When prostate cancer stem cells were enclosed in self-assembling nanomaterials made of peptides, the SAP stopped cancer stem cell colony formation and also stopped the division of cancer cells in laboratory cultures.

11 Mar 2011

Novartis new MS treatment receives Notice of Compliance in Canada

Novartis Pharmaceuticals Canada Inc. announced today that its new MS treatment, Gilenya, has received Notice of Compliance in Canada.

10 Mar 2011

TGen launches globalCure initiative to fight against pancreatic cancer

In an effort to improve treatment and one day find a cure for pancreatic cancer, the TGen Foundation today joined with key donors and community leaders to announce the creation of globalCure.

10 Mar 2011

Avinger completes patient enrollment in CONNECT trial to treat CTOs linked with PAD

Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.

10 Mar 2011

Future Medicine launches Neuropsychiatry

Future Medicine Ltd has today announced the launch of Neuropsychiatry – a new bimonthly title addressing all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world. Neuropsychiatry is published by Future Medicine Ltd (UK, London) renowned for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.

10 Mar 2011

Despite aspirin therapy, specific inflammatory pathways may influence risk of colorectal cancer

The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood.

10 Mar 2011

ISCO achieves major milestone in stem cell banking program

International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.

10 Mar 2011

Therapy News and Research

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

Texas Children's completes first phase of certification to implant SynCardia temporary Total Artificial Heart

Researchers uncover new disease mechanism in patients with CGD

IHS opens new GE Discovery ST PET/CT system at Laurel imaging facility

CWRU: Postmenopausal women need more dental checkups

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

SAP may serve as effective nanomaterial to prevent prostate cancer spread

Novartis new MS treatment receives Notice of Compliance in Canada

TGen launches globalCure initiative to fight against pancreatic cancer

Avinger completes patient enrollment in CONNECT trial to treat CTOs linked with PAD

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Biothera announces acquisition of AS1402 anti-cancer monoclonal antibody from Antisoma

Future Medicine launches Neuropsychiatry

Idera reports $6.0 million net loss for fourth quarter 2010

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

Despite aspirin therapy, specific inflammatory pathways may influence risk of colorectal cancer

ISCO achieves major milestone in stem cell banking program

Pilot entrepreneur creates ultra-luxe alcohol and addiction rehabilitation facility

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News